arabinose has been researched along with glucagon-like peptide 1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, JR; Bukhave, K; Hels, O; Holst, JJ; Krog-Mikkelsen, I; Tetens, I | 1 |
1 trial(s) available for arabinose and glucagon-like peptide 1
| Article | Year |
|---|---|
The effects of L-arabinose on intestinal sucrase activity: dose-response studies in vitro and in humans.
Topics: Arabinose; C-Peptide; Caco-2 Cells; Dose-Response Relationship, Drug; Double-Blind Method; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Humans; Insulin; Intestines; Male; Sucrase | 2011 |